Nomura spins off life science venture

Growing concern about Volcker rule is encouraging banks to offload their private equity businesses

Nomura has spun off a life science venture in the latest sign that the big banks are looking to hive off their private equity activities. US fund of funds HarbourVest Partners was also an investor in the business.

The Japanese bank has sold 100% of the life science buyout business, Phase4 Ventures, to the firm's management.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump